Multi-omics biomarkers aid prostate cancer prognostication
Zhuoran Xu, Mohamed Omar, Elisa Benedetti, Jacob Rosenthal, Renato Umeton, Jan Krumsiek, Mark M. Pomerantz, Eddie L. Imada, Massimo F. Loda, Luigi Marchionni
This study identifies multi-omics prognostic signatures for prostate cancer using transcriptomics and metabolomics data, showing their ability to stratify patients into distinct risk groups.
bioRxiv · Sep 20, 2022 · PreprintSystems Biology